They met, fell in love, started a gene therapy company — now they've raised $104 million to target diseases that were unreachable

The company's first target is Dravet syndrome, a rare genetic disorder marked by dozens of seizures a day.

Source: bizjournals.com Health Care:Physician Practices headlines - June 26, 2019 Category: American Health Authors: Ron Leuty Source Type: news